Deborah Robins
debrobins.bsky.social
Deborah Robins
@debrobins.bsky.social
Advocate for Duchenne muscular dystrophy healthcare and research. I champion patient partnership and co-design, direct democracy and ukulele.
On World Duchenne Awareness Day 2025, I ask researchers to stop pasting DMD prognosis with colonised fatalistic & outdated statistical
lifespans in publications. Update to modern biology and thus unpredictable prognoses! #DMD #WDAD2025 #Duchenne
September 6, 2025 at 9:00 AM
The Australian Consumer Partnerships in Research Aug 12, 2025 finalists showcase-Register to tune in wherever you are in the medical world.
ccrew.accesscr.com.au/cpir-2025/li...

#CPIR2025Awards #patientengagement #patientpartners #consumerpartnership #clinicalresearch
August 7, 2025 at 12:55 PM
Check out our Australian Consumer Partnership in Research Awards showcase event in August 2025. Nominations are about to open but meanwhile we are looking for Judges and Sponsorship. Check out the event website for all the information. ccrew.accesscr.com.au/cpir-2025/
CPIR 2025 – CCReW at AccessCR
ccrew.accesscr.com.au
February 19, 2025 at 2:30 AM
Reposted by Deborah Robins
try to figure that out before we go any further. And let’s be clear: there is precedence for *not* trying to exercise through illness: if someone had Duchenne’s muscular dystrophy and told you they couldn’t walk to the bathroom easily anymore, you wouldn’t ask them to do that 18/
November 20, 2024 at 11:27 AM
Reposted by Deborah Robins
Enjoying the celebration of 10-years of the John Walton Muscular Dystrophy Research Centre @newcastleuni.bsky.social Amazing to see how colleagues contributed to neuromuscular disease research, diagnostics, therapy and international networking!
November 24, 2024 at 4:23 PM
Reposted by Deborah Robins
Regenxbio $RGNX says gene therapy strengthened boys with Duchenne muscular dystrophy

Pivotal study started, top-line data could come early 2026. FDA accelerated approval filing to follow.

www.statnews.com/2024/11/18/d... $SRPT
Regenxbio says gene therapy strengthened boys with Duchenne muscular dystrophy
Based on a small trial with positive muscle performance data, Regenxbio is expected to pursue approval of its gene therapy for Duchenne muscular dystrophy.
www.statnews.com
November 18, 2024 at 12:19 PM
Reposted by Deborah Robins
Differentiating Juvenile Dermatomyositis from Muscular Dystrophy

A diagnostic approach to sooner diagnosis in juvenile dermatomyositis

In Arthritis & Rheumatology
acrjournals.onlinelibrary.wiley.com/doi/abs/10.1...
#Medsky
November 21, 2024 at 1:22 PM